| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |